查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1412624

In Silico臨床試驗市場：按治療領域、階段、產業分類 - 2024-2030 年全球預測

In Silico Clinical Trials Market by Therapeutic Area (Infectious Diseases, Oncology), Phase (Phase I, Phase II, Phase III), Industry - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年In Silico臨床試驗市場規模為30.1億美元，預計2024年將達31.9億美元，2030年將達到48.5億美元，複合年成長率為7.01%。

In Silico臨床試驗的全球市場

主要市場統計
基準年[2023] 30.1億美元
預測年份 [2024] 31.9億美元
預測年份 [2030] 48.5億美元
複合年成長率（%） 7.01%
電腦模擬臨床試驗市場-IMG1

FPNV定位矩陣

FPNV 定位矩陣對於評估In Silico臨床試驗市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對In Silico臨床試驗市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-In Silico臨床試驗市場的市場規模與預測是多少？

2-在In Silico臨床試驗市場的預測期內，需要考慮投資哪些產品、細分市場、應用和領域？

3-In Silico臨床試驗市場的技術趨勢和法律規範是什麼？

4-In Silico臨床試驗市場主要供應商的市場佔有率是多少？

5-進入In Silico臨床試驗市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球慢性病盛行率上升，需要有效藥物
      • 越來越需要更了解藥品和設備的安全性和有效性
      • 藥物研發研發費用大幅增加
    • 抑制因素
      • 新興經濟體對In Silico測驗的認知較低
    • 機會
      • In Silico的進展
      • 利用先進的計算建模和模擬工具
    • 任務
      • 蛋白質彈性、分子構象和混雜性問題
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第 6 章In Silico的電腦模擬臨床試驗市場

  • 感染疾病
  • 腫瘤學

第7章In Silico臨床試驗市場分階段

  • 第一階段
  • 第二階段
  • 第三階段

第 8 章In Silico臨床試驗市場：按行業

  • 醫療設備
  • 藥品

第9章北美和南美的電腦In Silico臨床試驗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太電腦In Silico臨床試驗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的In Silico臨床試驗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：按主要企業分類
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • Aganitha AI Inc.
    • GNS Healthcare
    • Insilico Medicine
    • InSilicoTrials Technologies
    • Instem Group of Companies
    • Labcorp Drug Development
    • Novadiscovery SAS
    • Thornton Tomasetti
    • ZMT Zurich MedTech AG
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-742BD517F94B

[191 Pages Report] The In Silico Clinical Trials Market size was estimated at USD 3.01 billion in 2023 and expected to reach USD 3.19 billion in 2024, at a CAGR 7.01% to reach USD 4.85 billion by 2030.

Global In Silico Clinical Trials Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.01 billion
Estimated Year [2024] USD 3.19 billion
Forecast Year [2030] USD 4.85 billion
CAGR (%) 7.01%
In Silico Clinical Trials Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the In Silico Clinical Trials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In Silico Clinical Trials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the In Silico Clinical Trials Market, highlighting leading vendors and their innovative profiles. These include Aganitha AI Inc., GNS Healthcare, Insilico Medicine, InSilicoTrials Technologies, Instem Group of Companies, Labcorp Drug Development, Novadiscovery SAS, Thornton Tomasetti, and ZMT Zurich MedTech AG.

Market Segmentation & Coverage

This research report categorizes the In Silico Clinical Trials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Therapeutic Area
    • Infectious Diseases
    • Oncology
  • Phase
    • Phase I
    • Phase II
    • Phase III
  • Industry
    • Medical Devices
    • Pharmaceutical
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the In Silico Clinical Trials Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the In Silico Clinical Trials Market?

3. What are the technology trends and regulatory frameworks in the In Silico Clinical Trials Market?

4. What is the market share of the leading vendors in the In Silico Clinical Trials Market?

5. Which modes and strategic moves are suitable for entering the In Silico Clinical Trials Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. In Silico Clinical Trials Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases worldwide and need for efficient drugs
      • 5.1.1.2. Growing need for better understanding of the safety and efficacy of a drug or a device
      • 5.1.1.3. Significant rise in R&D expenditure for drug development
    • 5.1.2. Restraints
      • 5.1.2.1. Low awareness about in silico trials in the developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in in silico clinical trials
      • 5.1.3.2. Utilization of use advanced computational modeling and simulation tools
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to protein flexibility, molecule conformation, and promiscuity
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. In Silico Clinical Trials Market, by Therapeutic Area

  • 6.1. Introduction
  • 6.2. Infectious Diseases
  • 6.3. Oncology

7. In Silico Clinical Trials Market, by Phase

  • 7.1. Introduction
  • 7.2. Phase I
  • 7.3. Phase II
  • 7.4. Phase III

8. In Silico Clinical Trials Market, by Industry

  • 8.1. Introduction
  • 8.2. Medical Devices
  • 8.3. Pharmaceutical

9. Americas In Silico Clinical Trials Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific In Silico Clinical Trials Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa In Silico Clinical Trials Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Aganitha AI Inc.
    • 13.1.2. GNS Healthcare
    • 13.1.3. Insilico Medicine
    • 13.1.4. InSilicoTrials Technologies
    • 13.1.5. Instem Group of Companies
    • 13.1.6. Labcorp Drug Development
    • 13.1.7. Novadiscovery SAS
    • 13.1.8. Thornton Tomasetti
    • 13.1.9. ZMT Zurich MedTech AG
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. IN SILICO CLINICAL TRIALS MARKET RESEARCH PROCESS
  • FIGURE 2. IN SILICO CLINICAL TRIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. IN SILICO CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. IN SILICO CLINICAL TRIALS MARKET DYNAMICS
  • FIGURE 7. IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 8. IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 10. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2023 VS 2030 (%)
  • FIGURE 12. IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. IN SILICO CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. IN SILICO CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. IN SILICO CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. IN SILICO CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IN SILICO CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 6. IN SILICO CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. IN SILICO CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 9. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 13. IN SILICO CLINICAL TRIALS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM IN SILICO CLINICAL TRIALS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM IN SILICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM IN SILICO CLINICAL TRIALS MARKET SIZE, BY INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 142. IN SILICO CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 143. IN SILICO CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. IN SILICO CLINICAL TRIALS MARKET LICENSE & PRICING